Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
mattiafalchetto.osti@uniroma1.it
Mattia Falchetto Osti
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
mattiafalchetto.osti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy
CANCER DIAGNOSIS & PROGNOSIS
2021
How technology can help in oncologic patient management during COVID-19 outbreak
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
2020
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study
IN VIVO
2020
One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2020
The role of vaginal brachytherapy in stage I endometrial serous cancer. a systematic review
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2020
Beyond BRCA1 and BRCA2: deleterious variants in DNA repair pathway genes in italian families with breast/ovarian and pancreatic cancers
JOURNAL OF CLINICAL MEDICINE
2020
Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study
CLINICAL BREAST CANCER
2020
Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas
JOURNAL OF NEURO-ONCOLOGY
2020
The perception of the information received from the doctor. A study on 103 onco-hematological patients with metastatic disease
ADVANCES IN SOCIAL SCIENCES RESEARCH JOURNAL
2020
Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
SCIENTIFIC REPORTS
2020
Post-mastectomy immediate breast reconstruction and adjuvant radiotherapy: long term results of a mono institutional experience
LA RADIOLOGIA MEDICA
2020
Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients with Head and Neck Tumors. A multicentric randomized study
ANTICANCER RESEARCH
2019
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment. A mono-institutional experience
RADIATION ONCOLOGY
2019
Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
SCIENTIFIC REPORTS
2019
Orbital radiotherapy plus concomitant steroids in moderate-to-severe graves’ ophthalmopathy. Good results after long-term follow-up
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2019
Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC)
LUNG CANCER
2019
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity
JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019
Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction)
LA RADIOLOGIA MEDICA
2019
Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule
LA RADIOLOGIA MEDICA
2019
Interventions to Reduce Neurological Symptoms in Patients with GBM Receiving Radiotherapy: From Theory to Clinical Practice
ANTICANCER RESEARCH
2018
« prima
< precedente
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
La radioterapia stereotassica frazionata extracranica e le terapie biologiche nel trattamento delle neoplasie solide metastatiche: analisi del controllo locale e della tossicità nei trattamenti combinati.
VALUTAZIONE DI FATTORI PROGNOSTICI CLINICO-PATOLOGICI IN PAZIENTI CON ADENOCARCINOMA DELLA PROSTATA A RISCHIO INTERMEDIO ED ALTO TRATTATI CON RADIOTERAPIA CURATIVA IPOFRAZIONATA ASSOCIATA AD ORMONOTERAPIA
Radioterapia stereotassica frazionata concomitante a immunoterapia o target-therapy nel trattamento delle metastasi cerebrali.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma